ArticleNPJ precision oncology2022

Deletions on 9p21 are associated with worse outcomes after anti-PD-1/PD-L1 monotherapy but not chemoimmunotherapy.

Ericka M Ebot et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.